Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.45x is 69% above its 3-year average of -26.91x, near the high end of its 3-year range (-932.17x–-6.01x).
97.74% above its 12-month average of -373.80x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -622.19x.
INTEREST COVERAGE RATIO
-8.45x
INTEREST COVERAGE RATIO AVG TTM
-373.80x
INTEREST COVERAGE RATIO AVG 3Y
-26.91x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+97.74%
CURRENT VS 3Y AVG
+68.59%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.65x
median of 459 covered companies
CURRENT VS SECTOR MEDIAN
-49.56%
vs the sector median at left
Onconetix, Inc.
Market Cap
$2.38M
Interest Coverage Ratio
-8.45x
TTM Avg
-373.80x
3Y Avg
-26.91x
5Y Avg
N/A
Market Cap
$2.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.51M
Interest Coverage Ratio
-238.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.52M
Interest Coverage Ratio
-81.61x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.56M
Interest Coverage Ratio
673.25x
TTM Avg
673.25x
3Y Avg
673.25x
5Y Avg
673.25x
Market Cap
$2.62M
Interest Coverage Ratio
-1.05x
TTM Avg
65.98x
3Y Avg
65.98x
5Y Avg
65.98x
Market Cap
$2.63M
Interest Coverage Ratio
-4606.42x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Onconetix, Inc. (ONCO) | $2.38M | -8.45x | -373.80x | -26.91x | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | N/A | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.25M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.51M | -238.27x | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | -81.61x | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | 673.25x | 673.25x | 673.25x | 673.25x |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | -1.05x | 65.98x | 65.98x | 65.98x |
| iSpecimen Inc. (ISPC)vs › | $2.63M | -4606.42x | N/A | N/A | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.93M | N/A | N/A | N/A | N/A |
Interest Coverage
-8.4x
Debt/Equity
0.01
Current Ratio
2.21
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -622.19x |
| 2026-03-31 | -932.17x |
| 2025-12-31 | -301.71x |
| 2025-09-30 | -6.90x |
| 2025-06-30 | -6.01x |
| 2025-03-31 | -7.39x |
| 2024-12-31 | -117.36x |
| 2024-09-30 | -6.87x |
| 2024-06-30 | -37.68x |
| 2024-03-31 | -26.83x |
| 2023-12-31 | -28.61x |
| 2023-09-30 | -16.68x |
| 2023-06-30 | -14.72x |
